TQC-3721

Primary purpose: To evaluate the effectiveness of inhaled TQC3721 suspension in the treatment of patients with moderate to severe COPD; Secondary purpose: To evaluate the safety and PK characteristics of inhaled TQC3721 suspension in the treatment of patients with moderate to severe COPD;